Glypican-1 has been associated with cardiac voltage-activated K+ currents and LV hypertrophy,50 while obscurin associates with LV hypertrophy and hypertrophic cardiomyopathy.51 This evidence concerns the gene OBSCN and hypertrophic cardiomyopathy.